Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.04 |
mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |